scholarly journals Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3

2015 ◽  
Vol 42 (1) ◽  
pp. 78-84 ◽  
Author(s):  
Xinsheng Wang ◽  
Xiangzhong Zhao ◽  
Xiaoling Wang ◽  
Jian Yao ◽  
Feifei Zhang ◽  
...  

Background: Twenty-six HOGA1 mutations have been reported in primary hyperoxaluria (PH) type 3 (PH3) patients with c.700 + 5G>T accounting for about 50% of the total alleles. However, PH3 has never been described in Asians. Methods: A Chinese child with early-onset nephrolithiasis was suspected of having PH. We searched for AGXT, GRHPR and HOGA1 gene mutations in this patient and his parents. All coding regions, including intron-exon boundaries, were analyzed using PCR followed by direct sequence analysis. Results: Two heterozygous mutations not previously described in the literature about HOGA1 were identified (compound heterozygous). One mutation was a successive 2 bp substitution at the last nucleotide of exon 6 and at the first nucleotide of intron 6, respectively (c.834_834 + 1GG>TT), while the other one was a guanine to adenine substitution of the last nucleotide of exon 6 (c.834G>A). Direct sequencing analysis failed to find these mutations in 100 unrelated healthy subjects and the functional role on splicing of both variants found in this study was confirmed by a minigene assay based on the pSPL3 exon trapping vector. In addition, we found a SNP in this family (c.715G>A, p.V239I). There were no mutations detected in AGXT and GRHPR. Conclusion: Two novel HOGA1 mutations were identified in association with PH3. This is the first description and investigation on mutant gene analysis of PH3 in an Asian.

Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 5032-5032
Author(s):  
Qian Li ◽  
Hui Zeng ◽  
Yong Xu ◽  
Min Zhou ◽  
Bing Chen ◽  
...  

Abstract The objective is to identify the gene mutations responsible for the deficiency of factor XI (FXI) in a Chinese pedigree. The FXI activity was tested with clotting assay. The F11 gene was amplified by PCR with direct sequencing. ClustalX-2.1-win and three online bioinformatics softwares were used to study the conservatism and harm of the mutation. The proband was a 70-year-old male and had a prolonged APTT of 67.8s. The corrected APTT was 28.3s and he had reduced FXI: activity of 0.8%. His son and daughter had normal APTT of 26s and 27.3s and FXI:C of 72% and 75%, respectively. DNA sequencing analysis showed the proband carried a compound heterozygous g.841C>T and g.1556G>A mutation , resulting in Ser281Stop and Trp519Stop, respectively, which caused premature termination of transcription in the F11. His son had the heterozygous g.841C>T mutation of F11 and his daughter had the heterozygous g.1556G>A mutation of F11. The three bioinformatics softwares indicated that the mutation had affected the function of the protein. The two nonsense mutations had been reported previously in different patient, but this is the first time to be reported in the proband, which was responsible for the decrease of FXI: activity. Disclosures No relevant conflicts of interest to declare.


2016 ◽  
Vol 31 (3) ◽  
pp. e22053 ◽  
Author(s):  
Saoussen M'dimegh ◽  
Cécile Aquaviva-bourdain ◽  
Asma Omezzine ◽  
Geneviéve Souche ◽  
Ibtihel M'barek ◽  
...  

Author(s):  
Prince Singh ◽  
Candace F. Granberg ◽  
Peter C. Harris ◽  
John C. Lieske ◽  
Jeffrey H. Licht ◽  
...  

2011 ◽  
Vol 96 (Supplement 1) ◽  
pp. A68-A69
Author(s):  
E. Williams ◽  
D. Bockenhauer ◽  
N. Smeulders ◽  
A. Barnacle ◽  
S. Choong ◽  
...  

2021 ◽  
Author(s):  
Libin Mei ◽  
Lingling Huang ◽  
Yanru Huang ◽  
Xiaoling Wu ◽  
Huang He ◽  
...  

Abstract Background: Premature ovarian insufficiency (POI) is a heterogeneous condition occurring when a woman experiences a loss of ovarian activity before the age of 40. It is one of the most common reproductive endocrine diseases in women of childbearing age. Here, we investigated the clinical manifestations and genetic features of a Chinese patient affected by POI.Methods: We applied next-generation whole-exome capture sequencing with Sanger direct sequencing to the proband and her clinically unaffected family members. Results: Two novel compound heterozygous mutations were identified in the PSMC3IP gene. The first is a splicing mutation (c.597+1G>T) that was inherited from her father, while the second mutation (c.268G>C p.D90H) was also discovered in her mother and younger sister. The two mutations were co-segregated with the disease phenotype in the family. Conclusions: To our knowledge, this is the first report of PSMC3IP mutations causing POI in the Chinese population. Our findings further support the key role of the PSMC3IP gene in the etiology of POI. However, additional studies are required to explore the underlying molecular mechanisms involved.


2018 ◽  
Vol 33 (8) ◽  
pp. 1443-1446 ◽  
Author(s):  
Lawrence Greed ◽  
Frank Willis ◽  
Lilian Johnstone ◽  
Sharon Teo ◽  
Ruth Belostotsky ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document